Dermatology News

Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications, have been found to be associated with new onset acne in women, according to a research letter published in Journal of the American Academy of Dermatology.

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference product manufacturer, Janssen Pharmaceuticals, which set timelines for their market entries.

Childhood cancer survivors are more than twice as likely to develop melanoma as the general population, according to findings published in Journal of Clinical Oncology.

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for physicians, who highly prioritized individual symptoms, according to data published in ACR Open Rheumatology.

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse cutaneous systemic sclerosis, according to data published in Arthritis Care & Research.

Between Groundhog Day’s prediction for 6 more weeks of winter and the recent cold fronts rushing into both northern and southern states, wintery weather may linger this year – and with it, the chance for frostbite could stick around, too.